Nucleolin is implicated in disease progression [68] and in cancer and it is known to limit Rac 1 (Ras-related C3 botulinum toxin substrate 1) signalling, thereby inhibiting cell death and promoting cell proliferation. The gene discussed is NUCLEOLIN; the disease is cancer.